DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Medtronic (NYSE:MDT) is currently navigating a landscape marked by both promising innovations and significant challenges.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

Considering these conducive trends, let’s examine the Medical – Devices & Equipment industry stocks in detail, beginning with the third choice: Stock #3: Medtronic plc (MDT ... continuous glucose ...